Following the formation of a new partnership last year, pharma giant Bayer and One Drop, a precision medicine solution provider founded in 2015, have announced the release of their first digital health program designed to lower the risk of heart disease.
One Drop will initially offer it to employers through its multi-condition program, but also plans to offer it soon to consumers through an app.
According to a statement, the digital-first approach to CVD (Cardiovascular disease) prevention provides a holistic set of digital tools and coaching that offers users personalized care, data gathering and subsequent actionable insights, all in a user-friendly mobile app. The program seeks to reduce the broader burden of disease for those at risk while lowering costs for employers and health plans.
“The life-altering potential of our cardiovascular disease prevention module would not have been possible without the support and deep expertise from our strategic partner, Bayer,” said Rachel Yap Martens, One Drop’s executive vice president of commercial solutions and corporate strategy. “The CVD prevention module is one of many outputs to come, thanks to our productive partnership that will help countless people improve their lives.”
Among the specific services the One Drop CVD prevention module offers are:
• Connected medical devices to capture blood pressure and weight that are automatically tracked alongside food, medications, physical activity, glucose, and A1C from thousands of other integrations.
• A combination of behavioral science principles, data science, and customized educational content to guide members towards positive habits in weight management, physical activity, and diet for a heart-healthy life.
• One-on-one health coaching by registered nurses specializing in CVD for personalized support and regular progress check-ins.
• AI-powered biometric predictions, including blood pressure insights to help members at risk for CVD understand how their blood pressure is trending and offer tactical recommendations and support in real-time.
"The new CVD prevention module comes from combining our respective expertise to jointly bridge the gap between healthcare and technology," said Jeanne Kehren, CIO and head of digital and commercial innovation, Bayer Pharmaceuticals. "This launch is an important milestone in our joint endeavor with One Drop to make integrated care a transformative solution for the patients and a key player in the healthcare industry."
New York-based One Drop started in 2015 as an app to help people with Type 1 and Type 2 diabetes track their metrics. Since then the company has been integrating devices, including glucometers and test strips.
Photo by johan63/Getty Images